Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-02-02

Clinical Trial Update: Tranexamic Acid (TXA) in Hip Arthroscopy [Phase 3]

View source ↗

Summary

Phase 3 trial of tranexamic acid in hip arthroscopy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Northwestern University | Conditions: Hip Pain Chronic, Hip Impingement Syndrome | Phase 3 | Status: WITHDRAWN